SKYLER GALLEGOS: Open Payments
NPI 1811554694 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 19 payments from 13 companies in 2025. Trend: 2023 $149 · 2024 $1,084 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $56 |
| ABBVIE INC. | 2 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Lilly USA, LLC | 2 | $29 |
| Solventum Corporation | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Stryker Corporation | 1 | $22 |
| Innovation Technologies Inc | 1 | $20 |
| Cranial Technologies, Inc | 1 | $20 |
Products named: JOURNAVX, CAPLYTA, QULIPTA, PREVENA, Exparel, GAMMA, UBRELVY, IRRISEPT.
Industry payments across UT — which companies pay providers there.
